CDX2 Modulation in Colorectal Cancer Dynamics

Summary

CDX2, a caudal‐related homeobox transcription factor, plays a central role in establishing and maintaining intestinal epithelial identity. In normal gut epithelium, CDX2 regulates genes governing cell differentiation, polarity and barrier function. In colorectal cancer, reduced CDX2 expression disrupts these homeostatic programmes, unleashing Wnt/β-catenin signalling, promoting proliferative expansion and facilitating tumour initiation. Epigenetic silencing through DNA methylation and histone deacetylation further diminishes CDX2 levels in a subset of tumours, particularly those arising via the serrated pathway or in the proximal colon. CDX2 loss is associated with aggressive histological features, therapy resistance and altered interactions with the tumour microenvironment, including immune infiltration. Restoring CDX2 expression or targeting downstream pathways offers a promising avenue for patient stratification and therapeutic intervention.

Research from Nature Portfolio

Recent studies have demonstrated that CDX2 mediates location-specific transcriptional programmes in colon stem cells. Proximal and distal colon organoids exhibit distinct CDX2-dependent gene expression profiles that regulate stemness and differentiation. In proximal colon cancers, DNA methylation silences CDX2, abrogating its tumour-suppressive programme and creating a permissive context for oncogenic BRAF mutations. Experimental loss of CDX2 in mouse organoids recapitulates human proximal tumour transcriptional signatures and accelerates BRAF-driven transformation, highlighting CDX2 as a gatekeeper of tissue-specific tumour dependencies.

CDX2 Modulation in Colorectal Cancer Dynamics publication trend

The graph below shows the total number of articles in cdx2 modulation in colorectal cancer dynamics across all publications each year (not limited to Nature Index journals).

Technical terms

CDX2: A homeobox transcription factor essential for intestinal epithelial differentiation and maintenance of gut identity.

DNA methylation: Addition of methyl groups to cytosine bases in DNA, often leading to repression of gene transcription.

Wnt/β-catenin signalling: A pathway regulating cell proliferation and fate, frequently hyperactivated in colorectal cancer.

Microsatellite instability: A condition of defective DNA mismatch repair resulting in accumulation of repeat sequence alterations.

Homeobox transcription factors: A family of proteins characterised by a conserved DNA-binding domain that controls developmental gene networks.

References

  1. Tissue-location-specific transcription programs drive tumor dependencies in colon cancer. Nature Communications (2024).
  2. The prognostic potential of CDX2 in colorectal cancer: Harmonizing biology and clinical practice. Cancer Treatment Reviews (2023).
  3. High-fat diet plus HNF1A variant promotes polyps by activating β-catenin in early onset colorectal cancer. JCI Insight (2023).
  4. CDX2 and SATB2 loss are associated with myeloid cell infiltration and poor survival in colorectal cancer. Cancer Immunology, Immunotherapy (2025).
  5. CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathway. Clinical Epigenetics (2018).
  6. CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression. Cell Death & Disease (2019).

About these summaries

This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.

Nature Index 2026 Cancer

Cancer incidence is on the rise. Countries are meeting the challenge in different ways, such as through nationwide action plans and broadening early detection programmes. However, coordinating these efforts to make them accessible, targeted and effective is a balancing act. In this supplement, we explore the factors that are shaping these first lines of defence and the research efforts that are informing them.

Nature Index 2026 Cancer
Access for free
Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.